Get Premium to unlock powerful stock data
NAS:BCTX (Canada)   Healthcare » Biotechnology
BriaCell Therapeutics Corp logo

BriaCell Therapeutics Corp $ 7.39 -0.24 (-3.15%)

Volume:
797,060
Avg Vol (1m):
2,182,230
Market Cap $:
112.81 Mil
Enterprise Value $:
113.20 Mil
PE Ratio:
At Loss
PB Ratio:
4.06
Warning! GuruFocus has detected with BCTX. Click here to check it out.
Also Trade In: Canada Germany
EMBED
5D 3M YTD 1Y 3Y 5Y 10Y All 10Y -%
Above Low: +NaN%
Below High: NaN%

BriaCell Therapeutics Corp Stock Institutional Ownership and Insider Ownership -

15.27
(Mil)
Shares Outstanding
0.44%
0.07 (Mil)
Institutional Ownership
0%
0.00 (Mil)
Insider Ownership
0.00%
0 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of BriaCell Therapeutics Corp. Peter Lynch prefers to buy companies with low institutional ownership.
EMBED

Insider ownership (%)

This is the historical insider ownership of BriaCell Therapeutics Corp. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

Top Fund Holders